Tim Pearson

Tim Pearson serves as a Member of the Board of Directors at Korro Bio, Inc. since November 2023 and has held the position of CEO at Carrick Therapeutics since June 2019. Pearson is also the Chairman of the Board at GlycoMimetics, a role undertaken in March 2014, and previously served as a Member of the Board of Directors at Ra Pharmaceuticals from May 2016 to January 2020. From May 2014 to February 2019, Pearson was the EVP and Chief Financial Officer at TESARO, and prior to that, held the same title at Catalyst Health Solutions, Inc. from August 2011 to July 2012, as well as MedImmune from September 1998 to August 2011. Tim Pearson earned a Bachelor of Science in Business Administration from the University of Delaware and a Master of Science in Finance from Loyola University Maryland.